Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (261-270 of 383) with videos related to

Pageof 39
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancerPaul J Mintz, Anna Cecilia Rietz, Marina Cardó-Vila, et al.
British Journal of Cancer|October 9, 2008
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancerP Mathew, P F Thall, S Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Iscience|February 17, 2023
Endothelial-to-osteoblast transition in normal mouse bone developmentSong-Chang Lin, Guoyu Yu, Yu-Chen Lee, et al.
Cells|October 23, 2021
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic ResonanceTravis C Salzillo, Vimbai Mawoneke, Joseph Weygand, et al.
Cancer Research|July 17, 2001
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathwayJ Yang, K Fizazi, S Peleg, et al.
Oncogene|November 30, 2021
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibitionYu-Chen Lee, Song-Chang Lin, Guoyu Yu, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
Plos One|January 10, 2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysFarshid Dayyani, Nila U Parikh, Andreas S Varkaris, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapyStephen Harland, John Staffurth, Arturo Molina, et al.
Pageof 39

Showing results (261-270 of 383) with videos related to

Sort By:
Pageof 39
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancerPaul J Mintz, Anna Cecilia Rietz, Marina Cardó-Vila, et al.
British Journal of Cancer|October 9, 2008
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancerP Mathew, P F Thall, S Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Iscience|February 17, 2023
Endothelial-to-osteoblast transition in normal mouse bone developmentSong-Chang Lin, Guoyu Yu, Yu-Chen Lee, et al.
Cells|October 23, 2021
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic ResonanceTravis C Salzillo, Vimbai Mawoneke, Joseph Weygand, et al.
Cancer Research|July 17, 2001
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathwayJ Yang, K Fizazi, S Peleg, et al.
Oncogene|November 30, 2021
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibitionYu-Chen Lee, Song-Chang Lin, Guoyu Yu, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
Plos One|January 10, 2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysFarshid Dayyani, Nila U Parikh, Andreas S Varkaris, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapyStephen Harland, John Staffurth, Arturo Molina, et al.
Pageof 39